Form 4: ReposiTrak CEO Randall Fields Sells Shares to Meet Charitable Commitments

Sentiment:

SEC Form 4 Filing


CEO Randall K. Fields sold shares of ReposiTrak, Inc. common stock on February 24 and 25, 2025, to meet charitable commitments under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Randall K. Fields, CEO of ReposiTrak, Inc., reported the sale of company stock.
  • The sales occurred on February 24 and 25, 2025.
  • A total of 2,500 shares were sold on February 24 at a weighted average price of $19.5984, with prices ranging from $19.445 to $20.06.
  • On February 25, 5,000 shares were sold at a weighted average price of $19.094, with prices ranging from $18.80 to $19.53.
  • The sales were executed under a Rule 10b5-1 trading plan adopted by Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust.
  • The trading plan was established to meet some of his charitable commitments.
  • Following the reported transactions, Fields directly owns 3,683,955 shares of common stock.
  • Fields also indirectly owns shares through various entities, including RK Fields Charitable 2022, LLC (289,500 shares), Riverview Financial Corp. (615,260 common shares and 531,432 Series B Preferred shares), his spouse (30,667 common shares and 12,322 Series B Preferred shares), and Fields Management, Inc. (333,643 shares).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports stock sales under a pre-arranged plan, which doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on current market information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a 10b5-1 plan are generally viewed as less informative.

Stakeholder Impact

  • Shareholders may react to the news of insider sales, although the pre-planned nature of the transactions under a 10b5-1 plan may mitigate concerns.
  • The sales are intended to fulfill charitable commitments, which could indirectly benefit various charitable organizations.

Key Dates

DateDescription
02/24/2025Sale of 2,500 shares of common stock at a weighted average price of $19.5984.
02/25/2025Sale of 5,000 shares of common stock at a weighted average price of $19.094.
02/26/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.